Current Locations:Home > PRODUCTS > IBI310
IBI310- recombinant human CTLA-4 fusion protein injection.

IBI31 is a humanized monoclonal antibody that specifically targeting CTLA-4, which down regulates immune response. Immune system is re-activated through blockade of CTLA-4 by IBI310, thus, re-augment immune response directing tumor. IBI310 has the potential to combine PD-1 mAb for the treatment of lung cancer, melanoma and renal carcinoma et cetera.
Copyright © 2011- Innovent Biologics, Inc.
Powered by RuiXi